SCIDEV LTD — Director's Dealing 2020

May 5, 2020

==> picture [276 x 72] intentionally omitted <==

Unit 1 8 Turbo Road Kings Park NSW 2148 Australia ABN 25 001 150 849

Email: admin@scidev.com.au Website: www.scidev.com.au ASX code: SDV

Companies Announcements Office Australian Stock Exchange

6[th] May 2020

Appendix 3Y – Lewis Utting

SciDev Limited (ASX:SDV; SciDev , or the Company ) releases an Appendix 3Y Notice with regard to an on-market acquisition of shares by the Company’s Managing Director and Chief Executive Officer, Lewis Utting.

On behalf of SciDev Limited

==> picture [108 x 52] intentionally omitted <==

Heath Roberts Company Secretary

---

For Further Information:

Corporate

Investors

Lewis Utting - Managing Director & Chief Craig Sainsbury – Market Eye Executive Officer Heath Roberts - Company Secretary craig.sainsbury@marketeye.com.au (+61) 02 9622 5185 0428 550 499

About SciDev

SciDev is a leader in the development and application of services, chemistry and process control for solidsliquid separation. SciDev brings together world-class technology, chemistry, management and manufacturing capabilities to solve pressing operational and environmental issues for the Mining, Water Treatment, Oil & Gas and Construction markets.

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SciDev Ltd ABN 25 001 150 849

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Lewis UTTING
Date of last notice	19/11/2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Not Applicable
Date of change	05/05/2020
No. of securities held prior to change	330,221 fully paid ordinary shares (Lewis Utting), 5,000,000 fully paid ordinary shares (Lehos and Utting Family Trust) 1,600,000 options: expiry 23072022, exercise price $0.10.
Class	Refer above
Number acquired	37,200 shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1 28/11/2018

Appendix 3Y Change of Director’s Interest Notice

Number disposed	0
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Av. $0.7085 per share
No. of securities held after change	367,421 fully paid ordinary shares (Lewis Utting), 5,000,000 fully paid ordinary shares (Lehos and Utting Family Trust) 1,600,000 options: expiry 23072022, exercise price $0.10.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On-market purchase

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil / Not Applicable Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

28/11/2018

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	Although not a closed period, written clearance sought and provided
If prior written clearance was provided, on what date was this provided?	05/05/2020

• See chapter 19 for defined terms.

Appendix 3Y Page 3 28/11/2018